Privia Health Group, Inc. (NASDAQ:PRVA) Receives $26.67 Average PT from Analysts

Shares of Privia Health Group, Inc. (NASDAQ:PRVA) have been given a consensus recommendation of “Buy” by the sixteen brokerages that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $26.67.

Several analysts have weighed in on the stock. Macquarie assumed coverage on shares of Privia Health Group in a research report on Monday, December 16th. They set an “outperform” rating and a $25.00 target price on the stock. JPMorgan Chase & Co. boosted their price objective on shares of Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a report on Friday, November 29th. Needham & Company LLC reissued a “buy” rating and issued a $30.00 target price on shares of Privia Health Group in a research report on Friday, March 21st. JMP Securities set a $29.00 price target on Privia Health Group in a research report on Friday, February 28th. Finally, Piper Sandler increased their price objective on Privia Health Group from $25.00 to $40.00 and gave the company an “overweight” rating in a report on Friday, February 28th.

Institutional Investors Weigh In On Privia Health Group

Several hedge funds have recently bought and sold shares of PRVA. Nordea Investment Management AB increased its holdings in shares of Privia Health Group by 33.1% during the 4th quarter. Nordea Investment Management AB now owns 349,773 shares of the company’s stock valued at $6,953,000 after purchasing an additional 86,910 shares in the last quarter. Victory Capital Management Inc. grew its position in Privia Health Group by 402.9% during the third quarter. Victory Capital Management Inc. now owns 179,049 shares of the company’s stock valued at $3,260,000 after buying an additional 143,446 shares during the period. Rhumbline Advisers grew its position in Privia Health Group by 1.3% during the fourth quarter. Rhumbline Advisers now owns 287,200 shares of the company’s stock valued at $5,615,000 after buying an additional 3,658 shares during the period. Franklin Resources Inc. increased its holdings in Privia Health Group by 2.2% in the third quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company’s stock valued at $23,092,000 after buying an additional 28,480 shares in the last quarter. Finally, Barclays PLC raised its position in shares of Privia Health Group by 240.3% in the third quarter. Barclays PLC now owns 224,018 shares of the company’s stock worth $4,079,000 after acquiring an additional 158,188 shares during the period. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Privia Health Group Stock Performance

Shares of PRVA stock opened at $22.88 on Monday. Privia Health Group has a fifty-two week low of $15.92 and a fifty-two week high of $26.04. The firm has a market capitalization of $2.76 billion, a price-to-earnings ratio of 228.82, a PEG ratio of 3.47 and a beta of 0.85. The stock’s 50-day simple moving average is $23.77 and its 200-day simple moving average is $21.12.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.